Phase 3 Recruiting Network
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medicat…
Sponsor: SWOG Cancer Research Network
NCT ID: NCT05929768
Sites in Mississippi: - Baptist Memorial Hospital and Cancer Center-Golden Triangle — Columbus, Mississippi
- Baptist Cancer Center-Grenada — Grenada, Mississippi
- University of Mississippi Medical Center — Jackson, Mississippi
- Baptist Memorial Hospital and Cancer Center-Union County — New Albany, Mississippi
- Baptist Memorial Hospital and Cancer Center-Oxford — Oxford, Mississippi
Phase 3 Recruiting Academic/Other
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radi…
Sponsor: NRG Oncology
NCT ID: NCT04852887
Sites in Mississippi: - Gulfport Memorial Hospital — Gulfport, Mississippi
Phase 3 Recruiting Academic/Other
This phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive (+) breast cancer in patients that had a pathologic complet…
Sponsor: Alliance for Clinical Trials in Oncology
NCT ID: NCT06876714
Sites in Mississippi: - Baptist Memorial Hospital and Cancer Center-Golden Triangle — Columbus, Mississippi
- Baptist Cancer Center-Grenada — Grenada, Mississippi
- Baptist Memorial Hospital and Cancer Center-Union County — New Albany, Mississippi
- Baptist Memorial Hospital and Cancer Center-Oxford — Oxford, Mississippi
- Baptist Memorial Hospital and Cancer Center-Desoto — Southhaven, Mississippi
Phase 3 Recruiting Academic/Other
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radia…
Sponsor: NRG Oncology
NCT ID: NCT06500455
Sites in Mississippi: - University of Mississippi Medical Center — Jackson, Mississippi
Phase 3 Recruiting Industry
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early b…
Sponsor: Stemline Therapeutics, Inc.
NCT ID: NCT06492616
Sites in Mississippi: - Baptist Clinical Research Institution — Oxford, Mississippi
Phase 3 Recruiting Industry
The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBC…
Sponsor: Novartis Pharmaceuticals
NCT ID: NCT05827081
Sites in Mississippi: - Jackson Oncology Associates — Jackson, Mississippi
Phase 3 Recruiting Industry
This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without durvalumab compared with investigator's choice chemotherapy in combination with pembrolizuma…
Sponsor: AstraZeneca
NCT ID: NCT06103864
Sites in Mississippi: - Research Site — Hattiesburg, Mississippi
Phase 2 Recruiting NIH
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally adva…
Sponsor: National Cancer Institute (NCI)
NCT ID: NCT05564377
Sites in Mississippi: - Baptist Memorial Hospital and Cancer Center-Golden Triangle — Columbus, Mississippi
- Baptist Cancer Center-Grenada — Grenada, Mississippi
- Gulfport Memorial Hospital — Gulfport, Mississippi
- Baptist Memorial Hospital and Cancer Center-Union County — New Albany, Mississippi
- Baptist Memorial Hospital and Cancer Center-Oxford — Oxford, Mississippi
Recruiting Academic/Other
This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies …
Sponsor: Wake Forest University Health Sciences
NCT ID: NCT06418204
Sites in Mississippi: - Baptist Memorial Hospital and Cancer Center-Golden Triangle — Columbus, Mississippi
- Baptist Cancer Center-Grenada — Grenada, Mississippi
- Baptist Memorial Hospital and Cancer Center-Union County — New Albany, Mississippi
- Baptist Memorial Hospital and Cancer Center-Oxford — Oxford, Mississippi
- Baptist Memorial Hospital and Cancer Center-Desoto — Southaven, Mississippi
Recruiting Industry
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…
Sponsor: Massive Bio, Inc.
NCT ID: NCT03452774
Sites in Mississippi: - Massive Bio SYNERGY-AI site — Hattiesburg, Mississippi